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Juvenile polyposis (JP) is an autosomal dominant syndrome in which affected patients develop upper- and/or lower-
gastrointestinal (GI) polyps. A subset of families with JP have germline mutations in the SMAD4 (MADH4) gene
and are at increased risk of GI cancers. To date, six families with JP have been described as having the same SMAD4
deletion (1244–1247delAGAC). The objective of the present study is to determine whether this deletion is a common
ancestral mutation or a mutational hotspot. DNA from members of four families with JP, from Iowa, Mississippi,
Texas, and Finland, that had this 4-bp deletion was used to genotype 15 simple tandem repeat polymorphism
(STRP) markers flanking the SMAD4 gene, including 2 new STRPs within 6.3 and 70.9 kb of the deletion.
Haplotypes cosegregating with JP in each family were constructed, and the distances of the closest markers were
determined from the draft sequence of the human genome. No common haplotype was observed in these four
families with JP. A 14-bp region containing the deletion had four direct repeats and one inverted repeat. Because
no common ancestor was suggested by haplotype analysis and the sequence flanking the deletion contains repeats
frequently associated with microdeletions, this common SMAD4 deletion in JP most likely represents a mutational
hotspot.
Juvenile polyps were first recognized as comprising a
distinct histopathologic entity in 1957 (Horrilleno et al.
1957), and a heritable form was described as “juvenile
polyposis coli” in 1964 (McColl et al. 1964). In 1974,
juvenile polyposis (JP [MIM 174900]) was divided into
three different subtypes, including JP coli, JP of infancy,
and generalized JP (Sachatello et al. 1974). In 1975, it
was established that there was a significant risk of gas-
trointestinal (GI) malignancy in members of a large fam-
ily with generalized JP, suggesting that the prevalent be-
lief that these polyps were benign with no malignant
potential was incorrect (Stemper et al. 1975). In 1998,
genetic linkage to markers on chromosome 18q21.1 was
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found in the same family (Howe et al. 1998b), and germ-
line mutations were identified in the SMAD4 gene (MIM
600993) (Howe et al. 1998c). In the latter report, three
patients with JP were described who had the same 4-bp
deletion in SMAD4 exon 9. In 1999, three additional
unrelated patients with JP were reported as having this
same deletion (Friedl et al. 1999; Roth et al. 1999).
Common ancestry has been implicated as the cause
for the high prevalence of specificMLH1 (MIM120436)
mutations in Finland (Moisio et al. 1996), BRCA1
(MIM 113705) mutations in Quebec (Tonin et al. 1998),
and BRCA2 (MIM 600185) mutations in northern Eu-
rope (Neuhausen et al. 1998). Another mechanism for
common mutations in apparently unrelated families is
that they result from mutational hotspots within genes
(Cooper and Krawczak 1990; Krawczak and Cooper
1991). Among 60 unrelated patients with familial ade-
nomatous polyposis of the colon (MIM 175100), 5 pa-
tients shared the same 5-bp deletion (3183–3187del-
ACAAA), and 5 additional patients shared a different
5-bp deletion (3926–3930delAAAAG). Since 3 of these
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10 patients’ parents did not have these mutations, the
high frequency of these specific changes could not be
attributed entirely to founder mutations. The latter mu-
tation occurred within a tandem repeat of 5 nt (AAAAG-
AAAAG), with one repeat being lost, which may have
resulted from slippage of DNA polymerase (Groden et
al. 1993). In multiple endocrine neoplasia type 2A (MIM
171400), 16 families with a C634R missense mutation
were determined to have 11 separate haplotypes by use
of six markers from a 318-kb region containing theRET
gene (MIM 164761), suggesting that this common sub-
stitution was not due to a founder effect (Gardner et al.
1994). The objective of the present study is to apply
haplotype analysis to the families with JP that shared a
4-bp deletion, to determine whether this is the result of
either an ancestral mutation or a mutational hotspot.
Informed consent was obtained from family members
for genetic studies, as well as for review of medical re-
cords and pathology specimens. Each of the four families
in this report are white, have had GI cancers, and do
not share surnames nor have known common relatives.
The Iowa kindred with JP is an extended white family
comprising 29 members with JP or GI cancer (Stemper
et al. 1975). Eleven individuals had developed colorectal
cancer and six had developed upper-GI (four stomach,
one duodenum, and one pancreas) cancers (Howe et al.
1998a). TheMississippi kindred with JP has 11members
with documented JP, of whom one developed gastric
cancer and another developed colorectal cancer (Sub-
ramony et al. 1994; Scott-Conner et al. 1995). Three
other members of this family died prior to the present
study and had had a history of unspecified GI malig-
nancies. The Finnish kindred with JP consists of 11 af-
fected individuals from five generations. Four individuals
are known to have upper-GI polyps, one died of gastric
cancer, and one died of metastatic colorectal cancer. One
other member died of metastatic adenocarcinoma of the
liver of unknown primary site and had gastric, esoph-
ageal, and colonic juvenile polyps. Three additional af-
fected family members each had one of the following:
leukemia, goiter, and a benign ovarian neoplasm of un-
known histology. The Texas kindred has five known af-
fected members from three generations. The matriarch
of the family had rectal, colonic, gastric, and duodenal
polyps and has four affected offspring who had colonic
polyps but no history of upper-GI polyps. One of these
offspring developed colon cancer at age 30 years.
DNA was extracted from peripheral blood by use of
a salting-out technique (Miller et al. 1988). DNA from
2 affected members (IV-22 and V-2) of the Iowa kindred
(Howe et al. 1998b) were amplified by PCR, along with
DNA from 10 members (5 affected, 4 at risk, and 1
spouse) of the Mississippi kindred, 2 affected siblings
from the Finnish kindred, and 7 members (4 affected
and 3 unaffected) of the Texas kindred with JP. PCR
was performed in a 10-ml volume that contained 25 ng
DNA from each individual, 0.5 pmol of each primer,
buffer (1.65 mM MgCl2, 50 mM KCl, 10 mM Tris, and
5% glycerol), 100 mmol each dNTP, and 0.2 U TaqDNA
polymerase. Amplification was performed in a thermo-
cycler for 30 s at 94C, 30 s at 55C, and 30 s at 72C,
for a total of 35 cycles. Samples were electrophoresed
through 6% denaturing polyacrylamide gels for 2–3 h
at 60W, the gels were silver stained (Bassam et al. 1991),
and genotypes were determined from the gels.
SMAD4 exons and their adjacent intron-exon
boundaries were used to perform BLAST searches of
the draft sequence of the human genome (Interna-
tional Human Genome Sequencing Consortium
2001) and the Celera genome sequence (Venter et al.
2001). The genomic structure of the SMAD4 gene
was determined from the draft sequence by align-
ment of exons through use of the Sequencher pro-
gram (Gene Codes). The genome-sequence segments
that contained SMAD4 were then searched for the
sequences of previously identified chromosome
18q21 STRPs. New STRPs were then sought by
alignment of 20-bp sequences of different of dinu-
cleotide-, trinucleotide-, and tetranucleotide-repeat
elements. When repeats were identified in the genome
sequence, flanking primer pairs were selected using
the Primer3 program. New candidate STRPs were
amplified from 51 control patients, to determine
their allele frequencies and heterozygosity, and were
then tested in families with JP. Genetic-mapping data
for each known marker were obtained from the Cen-
ter for Medical Genetics sex-averaged map and com-
plemented physical-mapping data from the White-
head Institute Center for Genome Research human
physical-mapping project (Human BAC Mapping
Data). Distances between each marker and the
SMAD4 gene were determined by alignment of the
human-genome sequences through use of the Se-
quencher program. Two novel polymorphic STRPs
were identified from BAC clone RP11-729G3
(GenBank accession number AP001374) and Celera
scaffold segments GA_x2KMHMRU853 and
GA_x2KMHMRU8FE. SMAD4GATA (GenBank ac-
cession number AF364127) consists of 11 repeats in
the BAC sequence and has three alleles (table 1). The
other STRP is an AT/CA repeat (SMAD4AT/CA
[GenBank accession number AF364126]), with 18
ATs, followed by 23 CAs in the BAC sequence, and
has 14 alleles.
The markers used to determine haplotypes are listed
in table 1 according to their physical- and genetic-map
positions. In addition, five STRPs mapped to BACs
where human-genome draft sequence data were avail-
able, and their distances from SMAD4 could be calcu-
lated with precision. Uncertainties created by gaps and
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Table 1
Haplotypes and Map Positions of Chromosome 18 Markers in Kindreds with JP
MARKER
ALLELES IN KINDRED FROM
DISTANCEa
(cM)
DISTANCE FROM
SMAD4 EXON 1
(kb) HETEROZYGOSITYIowa Mississippi Texas Finland
D18S970 3 6 3 3 93.9 … .67b
D18S1099 4 3 3 3, 5c 98.0 … .58d
D18S474 8 4 1 8, 10c 98.0 121.2 .82d
D18S1110 3 3 5 6 98.0 37.0 .75d
SMAD4 exon 11 31.4 …
SMAD4AT/CA 4 7 9 13 26.3 .90
Deletion 4 bp 4 bp 4 bp 4 bp 20.2 …
SMAD4GATA 2 3 2, 3c 3 50.7 .55
D18S46 7 5 6 10 !99.2e 132.9 .80d
GATA06 3 2 5 4 104.1 … .80b
D18S1156 3 2 2 2 104.1 … .54d
D18S851 3 2 5 4 105.5 … .55b
D18S484 1 1 3 3 105.5 … .72d
D18S539 3 2 5 4 105.5 … .63b
D18S487 5 5 6 6 106.3 … .81d
D18S846 2 2 2 2 107.5 … .38b
D18S977 1 4 4 4 ∼110 … .92b
a Based on the Center for Medical Genetics sex-averaged map.
b From the Cooperative Human Linkage Center.
c The specific allele cosegregating with JP could not be determined.
d From the Genome Database.
e Map position of D18S363, which is 165.5 kb telomeric to D18S46 (see text).
the lack of ordered segments in the BAC sequences were
checked against the Celera sequence (Venter et al. 2001).
SMAD4AT/CA was within the intron that is between
exons 9 and 10, just 6.1 kb from the 4-bp deletion found
in these four families. D18S363 was found to be 298
kb upstream from exon 1, which is consistent with the
finding by Hahn et al. (1996) but discordant with that
by Eppert et al. (1996), who placedD18S363 centromer-
ic to SMAD4. The last 50 kb of Celera scaffold
GA_x2KMHMRU853 contained exons 1–11 of the
SMAD4 gene, and the following genes were more telo-
meric: SMAD4GATA (50.7 kb from exon 1), D18S46
(133 kb), andD18S363 (298 kb). The centromeric STRP
D18S1110was present on both RP11-729G3 andCelera
scaffold GA_x2KMHMRU8FE; D18S474 was also
present on GA_x2KMHMRU8FE but not on RP11-
729G3. The 11 exons of the SMAD4 gene were distrib-
uted among 31,445 bp of genomic DNA, with the largest
intron spanning 9,479 bp between exons 9 and 10,
which contained the SMAD4AT/CA STRP. No matches
were found for D18S1099, D18S470, D18S473,
D18S970, D18S1156, and D18S851.
The results of haplotype analysis for the four families
are summarized in table 1. For the five markers centro-
meric to the deletion, there was no shared haplotype
between the families. The alleles in each family are all
different for the SMAD4AT/CA marker, which is only
6.1 kb downstream from the common deletion. There
was also no evidence of a shared haplotype with the
markers that were telomeric to the deletion.
We evaluated the possibility that the 4-bp deletion
could have been commonly inherited despite the absence
of a shared haplotype. The decrease in disequilibrium
over time decays as a function of (Sham 1997),n(1 v)
so that when a common haplotype is responsible for the
mutations that are found in two families, the probability
that both cases share the same haplotype is .2n(1 v)
The probability that none of the six possible haplotype
pairs from four families are shared is then [1 (1
. We set this probability to be .05 (the usual sig-2n 6v) ]
nificance criterion) and consider the marker SMAD4AT/
CA to be 0.006 cM from the 4-bp deletion. Solving for
the number of generations, n, we find that, with 5%
probability, 7,781 generations (233,430 years if one
assumes 30 years per generation) must have passed for
there not to be a shared haplotype among the cases if
they had a common ancestor. Another mechanism for
changes in alleles that originate from an ancestral allele
is mutation at the microsatellite loci, which may vary in
frequency from 0.2 to (Sajantila et al. 1999).33.3# 10
With the varied haplotypes flanking the common mu-
tation seen in the present study, both recombination and
mutation of microsatellites are less likely explanations
than a mutational hotspot in exon 9 of the SMAD4 gene.
Owing to the proximity of these markers, we conclude
that any common ancestor would likely date from the
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Figure 1 Possible mechanism of the 4-bp deletion through slipped mispairing. At the replication fork, the second AG direct repeat can
mispair with the complement of the first AG repeat, causing a loop on the upper strand that is excised by DNA repair enzymes. The resultant
upper-strand copies will have the 4-bp deletion, whereas the lower-strand copies will be the wild-type sequence.
dawn of the modern human species, which has been
estimated to be between 171,000 and 479,000 years ago
(Ingman et al. 2000).
Of the four families that we report, all include mem-
bers with upper-GI juvenile polyps and colorectal cancer.
In three of the four families, there are individuals with
gastric cancer, and consistent extraintestinal phenotypic
features have not been noted in these families. Friedl et
al. (1999) also found two families with the same 4-bp
deletion, one of which included three affected individ-
uals with stomach cancer and two with colon cancer
(Hofting et al. 1993). The other family was described
as having two affected brothers and an asymptomatic
carrier father. These findings suggest that this 4-bp de-
letion is associated with a more aggressive JP phenotype,
with generalized JP and upper- and lower-GI cancers.
Ancestral mutations are relatively common in some
diseases, such as hereditary nonpolyposis colorectal can-
cer (Moisio et al. 1996), cystic fibrosis (Morral et al.
1994), and breast/ovarian cancer (Neuhausen et al.
1998; Tonin et al. 1998). However, in many other dis-
eases, new mutations appear to arise from an increased
susceptibility due to specific DNA sequences. In this 4-
bp deletion, the same mutant sequence could result if
the deletion began at any of four consecutive bases.
Krawczak and Cooper (1991) examined 60 deletions of
!20 bp that were known to cause human diseases, to
identify sequence characteristics that might predispose
genes to microdeletion. They found that direct repeats
flanked or spanned the deletion in two-thirds of cases,
with the most common repeat length being 2–4 bp. In
the deletion that we report, a direct repeat of AG is
present in the first 2 bp of the deletion, and another
follows the deleted AGAC. There is another AG repeat
immediately after the second AG, and there is a fourth
AG repeat 2 bp downstream from this. One proposed
mechanism of this deletion would be slippage of DNA
polymerase through these repeat sequences. Another
proposed mechanism is slipped mispairing, in which the
second repeat pairs with the complement of the first
repeat at a DNA replication fork, which results in the
repeat and intervening sequence looping outward and
being excised by repair enzymes (fig. 1). Palindromic
(i.e., inverted repeat) sequences are another mechanism
that causes loops on a single DNA strand and were pres-
ent flanking the deletion in this case (CTT 2 bp 5′ and
AAG 2 bp 3′ to the deletion).
In the present study, the finding of different hap-
lotypes in four families with markers in close prox-
imity to the SMAD4 deletion effectively excludes the
possibility of a common ancestral mutation. The pres-
ence of direct and inverted repeats flanking the 4-bp
deletion, which are features commonly observed in
microdeletions, suggest that this area is instead a mu-
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tational hotspot. This mutation leads to a more vir-
ulent form of JP, with a high incidence of gastric and
colonic polyposis, as well as to gastric and colorectal
cancer.
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